Source link : https://www.newshealth.biz/health-news/new-assay-predicts-cancer-risk-in-barretts-esophagus/
TOPLINE: A new epigenetic assay is able to stratify patients with Barrett’s esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma within 5 years, aiding in clinical decision-making. METHODOLOGY: Researchers aimed to validate Esopredict (Previse), a polymerase chain reaction–based laboratory test that considers DNA methylation levels of four biomarkers, along […]
Author : News Health
Publish date : 2024-09-30 13:16:40
Copyright for syndicated content belongs to the linked Source.
Categories